Tg(Axin2-mCherry,-cre/ERT2)#Npa
Transgene Detail
|
|
| Symbol: |
Tg(Axin2-mCherry,-cre/ERT2)#Npa |
| Name: |
transgene insertion, Novartis Pharma AG |
| MGI ID: |
MGI:6724081 |
| Synonyms: |
Axin2-CreERT2 |
| Transgene: |
Tg(Axin2-mCherry,-cre/ERT2)#Npa Location: unknown
|
| Alliance: |
Tg(Axin2-mCherry,-cre/ERT2)#Npa page
|
|
| Strain of Origin: |
Not Specified
|
|
| Transgene Type: |
|
Transgenic (Inducible, Recombinase, Reporter) |
| Inducer: |
|
tamoxifen |
| Mutation: |
|
Insertion
|
| |
|
Tg(Axin2-mCherry,-cre/ERT2)#Npa expression driven by
1 gene
Transgene expression driven by:
|
| |
|
Mutation details: The transgene was generated by inserting a mCherry-IRES-Cre/ERT2 construct immediately after the 5' UTR in the 2nd exon of the mouse Axin2 locus in BAC clone RP23-374L11.
(J:293207)
|
|
|
|
Activity: |
 Tissue activity of this recombinase allele
|
|
Driver:
|
Axin2
(mouse)
|
| |
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:293207 Planas-Paz L, et al., YAP, but Not RSPO-LGR4/5, Signaling in Biliary Epithelial Cells Promotes a Ductular Reaction in Response to Liver Injury. Cell Stem Cell. 2019 Jul 3;25(1):39-53.e10 |
| All: |
2 reference(s) |
|
Analysis Tools
